Neurodegeneration in ALS/FTD is thought to be driven by both loss of nuclear function, as some nuclei become devoid of TDP-43, and cytoplasmic gain of toxic function, as evidenced by TDP-43 accumulation in cytoplasmic puncta. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.